Purpose: To determine the prevalence of dynamic respiratory tortuosity (DRT) of the vertebral artery ostium (VAO) as well as to evaluate its correlation with in-stent restenosis (ISR) and stent fracture. Methods: From March 2012 to June 2015, 178 consecutive patients (mean age 65.2±5.8 years; 124 men) with symptoms of atherosclerotic vertebrobasilar ischemia underwent angiography prior to stent implantation in the vertebral, subclavian, and/or carotid arteries. In this cohort, 54 patients (mean age 67.3±5.3 years; 40 men) had VAO stent implantation. Angiography of the vertebral artery was recorded in 2 phases with breath-hold: deep inspiration (DIP) and deep expiration (DEP). Obvious VAO tortuosity was defined as any VAO angle ≤120° in DIP. Obvious VAO-DRT was defined as any VAO angle increasing ≥60° from DIP to DEP. Computed tomography angiography (CTA) or digital subtraction angiography was used in follow-up to detect ISR and stent fracture. Results: Of the 178 patients in this study, 21 (11.8%) had obvious VAO tortuosity and 8 (4.5%) had obvious VAO-DRT. Two of the 21 patients with obvious VAO tortuosity also had obvious VAO-DRT. Three of the 54 VAO stent patients had VAO-DRT. There were no correlations between VAO-DRT and age, sex, risk factors, body mass index, chronic obstructive pulmonary disease, asthma, or obvious VAO tortuosity (p>0.05). Over a mean follow-up of 28±10 months, there were 4 (7.4%) asymptomatic VAO ISR cases. Two (3.7%) were occlusions at 6 and 12 months, respectively; both were associated with stent fracture in patients with obvious VAO-DRT before stenting. Both stents fractured at the tortuous VAO region. VAO-DRT was correlated with stent fracture (Spearman ρ=0.81, p<0.01) and ISR (Spearman ρ=0.55, p<0.01). Conclusion: VAO-DRT could be a risk factor for stent fracture and restenosis after VAO stent implantation. Angiography in both inspiration and expiration phases, especially the latter, should be considered before VAO stenting. Using a shorter stent to avoid crossing the tortuosity could reduce the occurrence of fracture.
HatanoTTsukaharaTMiyakoshiA. Stent placement for atherosclerotic stenosis of the vertebral artery ostium: angiographic and clinical outcomes in 117 consecutive patients. Neurosurgery. 2011;68:108–116.
2.
StaymanANNogueiraRGGuptaR.A systematic review of stenting and angioplasty of symptomatic extracranial vertebral artery stenosis. Stroke. 2011;42:2212–2216.
3.
JenkinsJSPatelSNWhiteCJ. Endovascular stenting for vertebral artery stenosis. J Am Coll Cardiol. 2010;55:538–542.
4.
SunXMaNWangB. The long term results of vertebral artery ostium stenting in a single center. J Neurointerv Surg. 2015;7:888–891.
5.
LinYHLiuYCTsengWY. The impact of lesion length on angiographic restenosis after vertebral artery origin stenting. Eur J Vasc Endovasc Surg. 2006;32:379–385.
6.
TaylorRASiddiqFSuriMF. Risk factors for in-stent restenosis after vertebral ostium stenting. J Endovasc Ther. 2008;15:203–212.
7.
OgilvyCSYangXNatarajanSK. Restenosis rates following vertebral artery origin stenting: does stent type make a difference?J Invasive Cardiol. 2010;22:119–124.
8.
WernerMBräunlichSUlrichM. Drug eluting stents for the treatment of vertebral artery origin stenosis. J Endovasc Ther. 2010;17:232–240.
9.
ChenXHuangQHongB. Drug-eluting stent for the treatment of symptomatic vertebral origin stenosis: Long-term results. J Clin Neurosci. 2011;8:47–51.
10.
WeberWMayerTEHenkesH. Efficacy of stent angioplasty for symptomatic stenoses of the proximal vertebral artery. Eur J Radiol. 2005;56:240–247.
11.
KimSRBaikMWYooSH. Stent fracture and restenosis after placement of a drug-eluting device in the vertebral artery origin and treatment with the stent-in-stent technique. Report of two cases. J Neurosurg. 2007;106:907–911.
12.
TsutsumiMKazekawaKOnizukaM. Stent fracture in revascularization for symptomatic ostial vertebral artery stenosis. Neuroradiology. 2007;49:253–257.
13.
TeraaMMollFLvan der WorpBH. Symptomatic vertebral artery stent fracture: a case report. J Vasc Interv Radiol. 2010;21:1751–1754.
14.
LuJLiuJWangD. Stent fracture and occlusion after treatment of symptomatic vertebral artery ostium stenosis with a self-expanding device. Interv Neuroradiol. 2014;20:755–760.
15.
SakaguchiMKitagawaKHougakuH. Mechanical compression of the extracranial vertebral artery during neck rotation. Neurology. 2003;61:845–847.
16.
AlbuquerqueFCFiorellaDHanP. A reappraisal of angioplasty and stenting for the treatment of vertebral origin stenosis. Neurosurgery. 2003;53:607–614.
17.
WangSPHuangRCZhuH. Safety and efficacy of a non-polymeric paclitaxel-eluting microporous stent in real-world percutaneous coronary intervention. Exp Ther Med. 2013;6:811–815.
18.
ChangCKHudedCPNolanBW. Prevalence and clinical significance of stent fracture and deformation following carotid artery stenting. J Vasc Surg. 2011;54:685–690.
19.
LinYTangXFuW. Stent fractures after superficial femoral artery stenting: risk factors and impact on patency. J Endovasc Ther. 2015;22:319–326.
KnirschWHaasNALewinMA. Longitudinal stent fracture 11 months after implantation in the left pulmonary artery and successful management by a stent-in-stent maneuver. Catheter Cardiovasc Interv. 2003;58:116–118.
22.
Damas-De Los SantosFColomboFZuffiA. Vertebral-subclavian bifurcation treatment. “The wedding ring technique” for a vertebral in-stent restenosis associated with stent fracture [in Spanish]. Gac Med Mex. 2015;151:655–659.
